RecruitingNCT06307262

European Registry of Transcatheter Repair for Tricuspid Regurgitation

European Registry of Transcatheter Repair for Tricuspid Regurgitation (EuroTR)


Sponsor

LMU Klinikum

Enrollment

3,000 participants

Start Date

Oct 23, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

To investigate clinical and survival outcomes following transcatheter tricuspid valve repair or replacement.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a European registry (a large database) collecting real-world data on patients who undergo a minimally invasive heart procedure to repair a leaky tricuspid valve (the valve on the right side of the heart), using catheter-based devices instead of open heart surgery. **You may be eligible if...** - You are 18 years or older - You have undergone or are undergoing a transcatheter (catheter-based, non-surgical) procedure to repair or replace your tricuspid valve using one of these devices: PASCAL, TriClip, TricValve, Evoque, or LuX-Valve **You may NOT be eligible if...** - You are under 18 years old - You have not undergone one of the listed transcatheter tricuspid valve procedures Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICET-TEER

T-TEER using the PACAL or TriClip device


Locations(1)

LMU Klinikum

Munich, Bavaria, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06307262


Related Trials